The Price of DNA IDs

Following natural disasters or violent political turmoil, DNA science can help identify victims. But what if a country can’t afford the technology?

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A mass grave in eastern BosniaWIKIMEDIA, POLARGEOWhen the remains of victims of political conflict or natural disasters are so badly damaged that they cannot be identified visually, DNA can often help. With modern genetics technologies, a small bit of tissue may be all that’s needed to determine who’s who. Unfortunately, in many areas of the world facing violent times, such as the current war zone that is Syria, the government and its citizens may not be able to afford such forensic technologies.

According to medical ethicist Alex John London of Carnegie Mellon University’s Center for Ethics and Policy, Lisa Parker of the Center for Bioethics and Health Law at the University of Pittsburgh, and Jay Aronson of Carnegie Mellon’s Center for Human Rights Science, this inequality in access to DNA science should stop. “In the context of poverty and deprivation, forensic identification might appear to be a luxury,” the trio wrote in a policy forum in Science last week (September 13). “But access to scientific identification of the missing and the dead after mass casualty events can be a starting point for healing, reconstruction, and the ability to access financial resources or to regain or maintain social status.”

Such large-scale efforts are becoming more and more common; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies